This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Kaspi.kz IPO
Ivashina, Victoria; Cekin, EselCase HBS-220007-EFinanceThis case follows Kaspi.kz, a private equity (Baring Vostok) co-owned retail bank in Central Asia that evolved into a fintech, payments and e-commerce company. It provides insights into private equity financing, portfolio company management, and initial public offering practices. In particular, the case focuses on (i) the bank's journey from a traditional bank that serviced only corporations to an online platform, and (ii) the timing and process ...Starting at €8.20
-
Corning: 156 Years of Innovation
Bowen, H. Kent; Purrington, CourtneyCase HBS-608108-EService and Operations ManagementThe executive team at Corning has committed to double the rate of new business creation per decade, while at the same time growing the company's current businesses, including glass substrates for LCD displays. Their strategy, built on more than 150 years of successful innovation, is to invent "keystone components" which uniquely enable other companies' products and earn high margins from its proprietary technology. As part of the company's missio...Starting at €8.20
-
TPG China: Daphne International
Ivashina, VictoriaCase HBS-813055-EFinanceTo maximize their effectiveness, color cases should be printed in color.Starting at €8.20
-
HCA, Inc. LBO Exit
Ivashina, VictoriaCase HBS-813056-EEntrepreneurshipThis case discusses the events following the 2006 $33.2 billion buyout of Hospital Corporation of America (HCA) by a consortium of private equity firms, including Bain Capital, KKR, and Merrill Lynch's private equity arm. The case highlights some of the core features of private equity investing. The first objective of the case is to allow students to understand a range of issues associated with the process of exit through an initial public offeri...Starting at €8.20
-
Granite Equity Partners, Teaching Note
Ivashina, Victoria; Shu, TerrenceTeaching Note HBS-820062-EFinanceThis teaching note accompanies HBS case 219040, "Granite Equity Partners," which follows the private equity firm as it evaluates the potential acquisition of Tyrell Corp., a Minnesota-based quality control biomaterials company. Granite Equity's fund was different from most other private equity funds in that it had a perpetual, or "evergreen," structure, meaning it invested in assets without a defined holding period. The case and teaching note des...Starting at €0.00
-
TowerBrook: ESG in Action (A)
Ivashina, Victoria; Trelstad, Brian; Conway, MeaghanCase HBS-221045-EFinancesome TowerBrook team members were excited about the company's growth potential, while others were concerned about the optics of its social impact. Overall, this case can be used to understand how private equity firms are integrating ESG considerations into their decision-making processes.Starting at €8.20
-
New Balance Athletic Shoe, Inc. (Abridged)
Bowen, H. Kent; Huckman, Robert S.; Knoop, Carin-Isabel; Preble, MatthewCase HBS-613006-EService and Operations ManagementConsiders whether New Balance, one of the world's five largest manufacturers of athletic footwear, should respond to Adidas' planned acquisition of Reebok-a transaction that would join the second- and third-largest companies in the industry. Highlights the unique aspects of New Balance's strategy-focusing on fit and performance by offering long-lived shoes in a wide variety of widths and eschewing celebrity endorsement of its products-and discuss...Starting at €8.20
-
Novartis AG: Science-Based Business
Bowen, H. Kent; Purrington, CourtneyCase HBS-608136-EService and Operations ManagementNovartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in 2007. Pharmaceuticals account for slightly over $24B of that total. In 2007, corporate R&D spending was $6.43B, or almost 17% of net sales. Novartis executive leaders believe in scientific progress and that large-scale investments in science will therefore r...Starting at €8.20
-
Ophthalmic Consultants of Boston and Dr. Bradford J. Shingleton (2004)
Bowen, H. Kent; Pancotto, MarceloCase HBS-608151-EService and Operations ManagementDr. Bradford Shingleton has developed some of the highest quality eye surgery techniques in the industry. He involves his nurses and technicians in creating a surgical service that is constantly improving. The case has many details about how Dr. Shingleton works with his staff and patients, and how the provider team focuses on patient care. A key measure of productivity for the surgery center is the time required in the operating room. Shingleton...Starting at €8.20
-
BC Partners: Gruppo Coin, Teaching Note
Ivashina, VictoriaTeaching Note HBS-217078-EFinanceTeaching note for case 217024.Starting at €0.00